Literature DB >> 3073089

The dawn phenomenon: its origin and contribution to early morning hyperglycemia in diabetes mellitus.

G B Bolli1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3073089

Source DB:  PubMed          Journal:  Diabete Metab        ISSN： 0338-1684


× No keyword cloud information.
  4 in total

1.  The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1991-01       Impact factor: 10.122

2.  Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.

Authors:  G Perriello; P De Feo; E Torlone; C Fanelli; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1990-01       Impact factor: 10.122

3.  Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency.

Authors:  P J Boyle; A Avogaro; L Smith; S D Shah; P E Cryer; J V Santiago
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

4.  Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans.

Authors:  Tineke van de Weijer; Esther Phielix; Lena Bilet; Evan G Williams; Eduardo R Ropelle; Alessandra Bierwagen; Roshan Livingstone; Peter Nowotny; Lauren M Sparks; Sabina Paglialunga; Julia Szendroedi; Bas Havekes; Norman Moullan; Eija Pirinen; Jong-Hee Hwang; Vera B Schrauwen-Hinderling; Matthijs K C Hesselink; Johan Auwerx; Michael Roden; Patrick Schrauwen
Journal:  Diabetes       Date:  2014-10-28       Impact factor: 9.461
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.